ClinPhone Pro
Our next-generation unified RTSM / IRT platform, with dedicated radioligand therapy capabilities designed to manage the operational, supply, and scheduling requirements specific to RLT studies.
Learn MoreShort isotope half-lives, dose-scheduling dependencies, and specialized site logistics. Our RTSM technology and experts are built to hold that complexity, from first participant in to database lock.
RLT specialists working alongside our RTSM and clinical supply teams under one roof.
The products and expertise we bring to radiopharmaceutical and RLT trials, from dose scheduling and supply through to eCOA and study-design consultancy.
Solutions
Our next-generation unified RTSM / IRT platform, with dedicated radioligand therapy capabilities designed to manage the operational, supply, and scheduling requirements specific to RLT studies.
Learn MoreStreamlined, ready-to-deploy RTSM on the same platform and quality framework, with go-live in about four weeks. A right-fit option for early-phase radiopharmaceutical studies that need proven capability fast.
Learn MoreElectronic Clinical Outcome Assessment through our Kayentis partnership, available as an integrated RTSM plus eCOA solution to capture patient-reported symptoms and quality-of-life data alongside randomization and dosing.
Learn MoreSupply-chain and randomization consultancy plus expert training, designed to de-risk dose-scheduling and supply decisions before and during a radiopharmaceutical study.
Learn MoreServices
End-to-end RTSM design, implementation, integration, validation, deployment, and support for radiopharmaceutical protocols, delivered by an embedded team of experts.
Learn MoreExpert design of randomization and stratification strategy for dose-escalation, dosimetry, and comparator-controlled radiopharmaceutical protocols.
Learn MoreForecasting and supply modeling to protect continuity of short half-life IMP that cannot be held in stock.
Learn MoreThe four capability areas behind every study we run, applied to the specific demands of radiopharmaceutical and RLT trials.
Blocked, stratified, and dynamic randomization for dose-escalation, dosimetry, and comparator-controlled radiopharmaceutical protocols.
Dose-scheduling dependencies, depot-to-site logistics, and expiry management for short half-life isotopes and made-to-order doses.
Dosing-window scheduling, site readiness across nuclear medicine facilities, participant replacement, and emergency unblinding.
Audit trails, data-change reporting, and real-time dashboards designed to support inspection readiness for radiopharmaceutical submissions.

A look at how standardized configurations and expert support shortened study start-up — and what teams running Phase II and III trials can take from it.
July 24, 2026
Talk with our RTSM experts about the dose-scheduling, supply, and data challenges specific to your radiopharmaceutical protocol.